Fulcrum Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Fulcrum Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2018 to Q2 2024.
  • Fulcrum Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 62.3M shares, a 0.69% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 62.3M +428K +0.69% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 62.1M +382K +0.62% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 61.9M +9.82M +18.8% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 61.8M +9.77M +18.8% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 61.8M +20.8M +50.8% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 61.8M +21.1M +51.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 52.1M +11.5M +28.2% Dec 31, 2022 10-K 2024-02-27
Q3 2022 52M +11.5M +28.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 41M +8.3M +25.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 40.7M +8.01M +24.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 40.6M +12.6M +44.8% Dec 31, 2021 10-K/A 2023-06-26
Q3 2021 40.5M +13.1M +47.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 32.7M +5.25M +19.1% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 32.7M +9.31M +39.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 28.1M +4.73M +20.3% Dec 31, 2020 10-K/A 2023-06-26
Q3 2020 27.5M +4.12M +17.6% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 27.5M +24.7M +892% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 23.4M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 23.3M +20.5M +736% Dec 31, 2019 10-K/A 2023-06-23
Q3 2019 23.3M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 2.77M Jun 30, 2019 10-Q 2019-08-26
Q4 2018 2.79M Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.